High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples